case_images: PMC11753364_01
case_images: PMC11753364_02
case_images: Clinical course between the first administration of rituximab therapy, first infusion of obinutuzumab and last follow-up. Relapse, urine protein: creatinine ratio > 2 mg/mg. MMF, mycophenolate mofetil; FK, tacrolimus
case_images: 467_2024_6570_Fig1_HTML.jpg
case_images: PMC11753364_02_467_2024_6570_Fig1_HTML.jpg
case_images: Fig1
case_images: The clinical course between the first administration of rituximab and last follow-up is shown in Fig. 1.